These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
162 related articles for article (PubMed ID: 33618734)
1. Immune infiltrating cells in cholangiocarcinoma may become clinical diagnostic markers: based on bioinformatics analysis. Zhang Y; Chen S; Li J; Dai W; Qian Y World J Surg Oncol; 2021 Feb; 19(1):59. PubMed ID: 33618734 [TBL] [Abstract][Full Text] [Related]
2. Wu J; Guo Y; Zuo ZF; Zhu ZW; Han L World J Gastroenterol; 2023 May; 29(19):2961-2978. PubMed ID: 37274806 [TBL] [Abstract][Full Text] [Related]
3. CeRNA regulatory network-based analysis to study the roles of noncoding RNAs in the pathogenesis of intrahepatic cholangiocellular carcinoma. Xu W; Yu S; Xiong J; Long J; Zheng Y; Sang X Aging (Albany NY); 2020 Jan; 12(2):1047-1086. PubMed ID: 31956102 [TBL] [Abstract][Full Text] [Related]
4. [A comparative study of intrahepatic cholangiocarcinoma and hepatocellular carcinoma with reference to clinical features and prognosis]. Hu JY; Zhou HB; Liu WD; Zhang J; Hu HP; Liu J Zhonghua Gan Zang Bing Za Zhi; 2019 Jul; 27(7):511-515. PubMed ID: 31357776 [No Abstract] [Full Text] [Related]
5. Combined hepatocellular and cholangiocarcinoma originating from the same clone: a pathomolecular evidence-based study. Zhao Q; Yu WL; Lu XY; Dong H; Gu YJ; Sheng X; Cong WM; Wu MC Chin J Cancer; 2016 Aug; 35(1):82. PubMed ID: 27552844 [TBL] [Abstract][Full Text] [Related]
6. Identification of Four Immune Subtypes Characterized by Distinct Composition and Functions of Tumor Microenvironment in Intrahepatic Cholangiocarcinoma. Job S; Rapoud D; Dos Santos A; Gonzalez P; Desterke C; Pascal G; Elarouci N; Ayadi M; Adam R; Azoulay D; Castaing D; Vibert E; Cherqui D; Samuel D; Sa Cuhna A; Marchio A; Pineau P; Guettier C; de Reyniès A; Faivre J Hepatology; 2020 Sep; 72(3):965-981. PubMed ID: 31875970 [TBL] [Abstract][Full Text] [Related]
7. SIRPα and PD1 expression on tumor-associated macrophage predict prognosis of intrahepatic cholangiocarcinoma. Yang H; Yan M; Li W; Xu L J Transl Med; 2022 Mar; 20(1):140. PubMed ID: 35317832 [TBL] [Abstract][Full Text] [Related]
8. The diagnostic and prognostic value of MRP8/MRP14 in intrahepatic cholangiocarcinoma. Jin GZ; Dong W; Dong H; Yu H; Chen J; Yu WL; Li AJ; Cong WM; Wu MC Oncotarget; 2015 Nov; 6(36):39357-64. PubMed ID: 26472105 [TBL] [Abstract][Full Text] [Related]
9. Oncostatin M expression and Liu Q; Lan T; Song Y; Cai J; Yu X; Chen W Aging (Albany NY); 2020 Nov; 12(21):21518-21543. PubMed ID: 33216732 [TBL] [Abstract][Full Text] [Related]
10. [Evaluation of immunohistochemical markers for differential diagnosis of hepatocellular carcinoma from intrahepatic cholangiocarcinoma]. Dong H; Cong WL; Zhu ZZ; Wang B; Xian ZH; Yu H Zhonghua Zhong Liu Za Zhi; 2008 Sep; 30(9):702-5. PubMed ID: 19173916 [TBL] [Abstract][Full Text] [Related]
11. Clinicopathological Features and Prognosis of Intrahepatic Cholangiocarcinoma After Liver Transplantation and Resection. Jung DH; Hwang S; Song GW; Ahn CS; Moon DB; Kim KH; Ha TY; Park GC; Hong SM; Kim WJ; Kang WH; Kim SH; Yu ES; Lee SG Ann Transplant; 2017 Jan; 22():42-52. PubMed ID: 28123170 [TBL] [Abstract][Full Text] [Related]
12. Novel immunohistochemical markers differentiate intrahepatic cholangiocarcinoma from benign bile duct lesions. Bertram S; Padden J; Kälsch J; Ahrens M; Pott L; Canbay A; Weber F; Fingas C; Hoffmann AC; Vietor A; Schlaak JF; Eisenacher M; Reis H; Sitek B; Baba HA J Clin Pathol; 2016 Jul; 69(7):619-26. PubMed ID: 26729014 [TBL] [Abstract][Full Text] [Related]
13. Expression of MUC1 and MUC2 mucin antigens in intrahepatic bile duct tumors: its relationship with a new morphological classification of cholangiocarcinoma. Higashi M; Yonezawa S; Ho JJ; Tanaka S; Irimura T; Kim YS; Sato E Hepatology; 1999 Dec; 30(6):1347-55. PubMed ID: 10573510 [TBL] [Abstract][Full Text] [Related]
14. Double primary hepatic cancer (hepatocellular carcinoma and intrahepatic cholangiocarcinoma) originating from hepatic progenitor cell: a case report and review of the literature. Hu J; Yuan R; Huang C; Shao J; Zou S; Wang K World J Surg Oncol; 2016 Aug; 14(1):218. PubMed ID: 27535234 [TBL] [Abstract][Full Text] [Related]
15. The Ability to Diagnose Intrahepatic Cholangiocarcinoma Definitively Using Novel Branched DNA-Enhanced Albumin RNA In Situ Hybridization Technology. Ferrone CR; Ting DT; Shahid M; Konstantinidis IT; Sabbatino F; Goyal L; Rice-Stitt T; Mubeen A; Arora K; Bardeesey N; Miura J; Gamblin TC; Zhu AX; Borger D; Lillemoe KD; Rivera MN; Deshpande V Ann Surg Oncol; 2016 Jan; 23(1):290-6. PubMed ID: 25519926 [TBL] [Abstract][Full Text] [Related]
16. Nomogram based on inflammatory indices for differentiating intrahepatic cholangiocarcinoma from hepatocellular carcinoma. Chen L; Zeng F; Yao L; Fang T; Liao M; Long J; Xiao L; Deng G Cancer Med; 2020 Feb; 9(4):1451-1461. PubMed ID: 31903730 [TBL] [Abstract][Full Text] [Related]
17. [Modern knowledge and development trend of intrahepatic cholangiocellular carcinoma]. Wang Q; Zhou HB; Hu HP Zhonghua Gan Zang Bing Za Zhi; 2017 May; 25(5):336-338. PubMed ID: 28763838 [TBL] [Abstract][Full Text] [Related]
18. ACSL4 serves as a novel prognostic biomarker correlated with immune infiltration in Cholangiocarcinoma. Liu S; Fan S; Wang Y; Chen R; Wang Z; Zhang Y; Jiang W; Chen Y; Xu X; Yu Y; Li C; Li X BMC Cancer; 2023 May; 23(1):444. PubMed ID: 37193981 [TBL] [Abstract][Full Text] [Related]